These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23683309)

  • 1. Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression.
    Lara DR; Bisol LW; Munari LR
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2111-7. PubMed ID: 23683309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
    J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors connected with efficacy of single ketamine infusion in bipolar depression].
    Permoda-Osip A; Skibińska M; Bartkowska-Sniatkowska A; Kliwicki S; Chłopocka-Woźniak M; Rybakowski JK
    Psychiatr Pol; 2014; 48(1):35-47. PubMed ID: 24946433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Ketamine for Depression: A Systematic Review.
    Rosenblat JD; Carvalho AF; Li M; Lee Y; Subramanieapillai M; McIntyre RS
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 30995364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of repeated subanaesthetic ketamine infusion in depression.
    Zhou YL; Liu WJ; Wang CY; Zheng W; Lan XF; Weng SY; Ning YP
    J Psychopharmacol; 2021 Feb; 35(2):159-167. PubMed ID: 32720857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible Affective Switch Associated With Intravenous Ketamine Treatment in a Patient With Bipolar I Disorder.
    Alison McInnes L; James-Myers MB; Turner MS
    Biol Psychiatry; 2016 May; 79(9):e71-e72. PubMed ID: 26229040
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ketamine for treatment of acute depression].
    Hjerrild S; Bjerre J; Pedersen RH; Videbech P
    Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?
    Rybakowski JK; Permoda-Osip A; Skibinska M; Adamski R; Bartkowska-Sniatkowska A
    Hum Psychopharmacol; 2013 Jan; 28(1):87-90. PubMed ID: 23124710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine-induced affective switch in a patient with treatment-resistant depression.
    Banwari G; Desai P; Patidar P
    Indian J Pharmacol; 2015; 47(4):454-5. PubMed ID: 26288483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid antidepressant effect of S-ketamine in schizophrenia.
    Bartova L; Papageorgiou K; Milenkovic I; Dold M; Weidenauer A; Willeit M; Winkler D; Kasper S
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):980-982. PubMed ID: 30041987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
    Andrade C
    J Clin Psychiatry; 2017 Jul; 78(7):e852-e857. PubMed ID: 28749092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression.
    Romeo B; Choucha W; Fossati P; Rotge JY
    Psychiatry Res; 2015 Dec; 230(2):682-8. PubMed ID: 26548981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population.
    Shiroma PR; Velit-Salazar MR; Vorobyov Y
    Clin Drug Investig; 2022 Jul; 42(7):549-566. PubMed ID: 35672558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?
    Bottemanne H; Bonnard E; Claret A; Petit AC; Gaillard R; Fossati P
    J Clin Psychopharmacol; 2020; 40(6):636-638. PubMed ID: 33009225
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.
    Andrade C
    J Clin Psychiatry; 2017 Apr; 78(4):e415-e419. PubMed ID: 28448702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
    Baune BT; Caliskan S; Todder D
    Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions.
    Dale RM; Bryant KA; Thompson NR
    J Clin Psychopharmacol; 2020; 40(1):75-79. PubMed ID: 31834094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.